Cervical dystonia is the most common form of focal dystonia in adults. It is characterized by involuntary contraction of neck muscles, causing abnormal posture and movements of the head. Pain is present in about 75% of patients and usually considered the major cause of disability in these ...
FDA Approves Otsuka and Lundbeck’s ABILIFY ASIMTUFII® (aripiprazole), the First Once-Every-Two-Months Long-acting Injectable (LAI) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults PRINCETON, NJ and DEERFIELD, IL –(April 2...
It is important to contact your healthcare provider if you experience prolonged, abnormal muscle spasms or contractions, which may be signs of a condition called dystonia. These are not all the possible side effects of ABILIFY MAINTENA.
This is the next step once the diagnosis of true dystonia is secured. Treatment in dystonia can be classified as etiology-based vs. symptomatic. While most treatments remain symptom-based, etiology-based treatments exist for a few forms of dystonia (“don’t-miss” diagnoses”) and can provide...
Botulinum toxin is widely used in medicine for the treatment of spasticity and focal dystonia, for the treatment of chronic migraine, facial hemispasm, and facial aesthetic treatments. Generally, botulinum toxin treatment is a safe procedure when it is conducted by clinicians with expertise and ...
Merz Neurosciences announced that the U.S. Food and Drug Administration approved a treatment for chronic drooling in adults.
Schizophrenia(≥4% incidence and at least twice the rate of placebo for REXULTI vs. placebo): weight increased Dystonia:Symptoms of dystonia may occur in susceptible individuals during the first days of treatment and at low doses. Pregnancy:Adequate and well-controlled studies to assess the risks...
alone as maintenance treatment of bipolar I disorder in adults It is not known if ABILIFY MAINTENA is safe and effective in children under 18 years of age. Please see FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE for ABILIFY MAINTENA....
Supernus Pharmaceuticals, Inc. announced today that the FDA approved Onapgo (apomorphine hydrochloride) injection, formerly known as SPN-830, as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults
Schizophrenia(≥4% incidence and at least twice the rate of placebo for REXULTI vs. placebo): weight increased Dystonia:Symptoms of dystonia may occur in susceptible individuals during the first days of treatment and at low doses. Pregnancy:Adequate and well-controlled studies to ...